Our strategy
We develop and support life science to remove the barriers that prevent promising discoveries from becoming available to patients.
We identified areas with under-served healthcare needs – motor neuron disease, chronic respiratory infection, global health, rare disease, and childhood cancer – where our expertise in translational science can help the most. We call these ‘Translational Challenges’.
We collaborate with others already working in those areas to create better diagnostics and treatments by providing investment, expert scientific support and commercialisation advice.
Our Translational Challenges
Each Translational Challenge at LifeArc targets a specific area or disease with life science research that’s ripe for translation, and currently immature pipelines to get these discoveries to patients. We bring our science, advice and funding to these challenges, and also work closely with partners to tap into their expertise and capabilities.
Motor Neuron Disease
Our vision is a world where motor neuron disease is preventable and treatable.
Chronic Respiratory Infection
Our vision is improved quality of life for those living with cystic fibrosis and bronchiectasis.
Global Health
Our vision is a world with affordable and accessible solutions to better understand, treat, and prevent infectious diseases.
Rare Disease
Our vision is an ecosystem working together to get discoveries and treatments to rare disease patients faster.
Childhood Cancer
Our vision is to drive life-changing innovations for children with cancer.
Focus on the under-served patient
As an independent, self-funded charity, we can focus on finding solutions to medical challenges that may be overlooked due to their complexity, high-risk nature, or commercial uncertainty.
We’re focused on delivering what patients tell us they most need, whether that’s a transformative new drug, diagnostic, device or digital solution.
There are many organisations and researchers already doing incredible work in these areas. Often, we seek to partner with them. Sometimes, we simply act as a bridge between experts.
A future proof LifeArc
We want to continue creating change for patients and building partnerships, long-term.
That means having a plan in place around our financial sustainability. Part of that is in our funding structure, including our early venture funding.
But we’re also concentrating on developing and retaining talent and building our reputation as a leader in translational science.
Looking for more info about our approach and operations?
Latest news
-
First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Read more: First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases -
New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
Read more: New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya -
LifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership
Read more: LifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership